BAUSCH HEALTH AMERICAS, INC.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Subsidiary
Employees
3.1K
Market Cap
-
Website
http://www.bauschhealth.com

Safety and Gastrointestinal Effects of Intravenous Methylnaltrexone

Phase 2
Completed
Conditions
Interventions
First Posted Date
2011-06-07
Last Posted Date
2019-11-27
Lead Sponsor
Bausch Health Americas, Inc.
Target Recruit Count
12
Registration Number
NCT01367587
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States

Methylnaltrexone in Patients With Opioid-Induced Bowel Dysfunction

Phase 2
Completed
Conditions
Interventions
First Posted Date
2011-06-07
Last Posted Date
2019-11-27
Lead Sponsor
Bausch Health Americas, Inc.
Target Recruit Count
39
Registration Number
NCT01367574
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States

Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone in Volunteers With Impaired Hepatic Function

Phase 1
Completed
Conditions
Interventions
First Posted Date
2011-06-07
Last Posted Date
2019-11-27
Lead Sponsor
Bausch Health Americas, Inc.
Target Recruit Count
24
Registration Number
NCT01367522
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States

Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function

First Posted Date
2011-06-07
Last Posted Date
2023-04-12
Lead Sponsor
Bausch Health Americas, Inc.
Target Recruit Count
15
Registration Number
NCT01367561
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States

Evaluate the Pharmacokinetics (PK) of Methylnaltrexone (MNTX) in Healthy Adult Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2011-06-06
Last Posted Date
2019-11-29
Lead Sponsor
Bausch Health Americas, Inc.
Target Recruit Count
20
Registration Number
NCT01366326
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States

Pharmacokinetics and Bioavailability Comparison of Two Different Formulations of MNTX Tablets

First Posted Date
2011-06-06
Last Posted Date
2019-11-27
Lead Sponsor
Bausch Health Americas, Inc.
Target Recruit Count
24
Registration Number
NCT01366352
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States

Study of Pharmacokinetics, Safety and Tolerability of Intravenous Methylnaltrexone Bromide

Phase 1
Completed
Conditions
Interventions
First Posted Date
2011-06-06
Last Posted Date
2019-11-27
Lead Sponsor
Bausch Health Americas, Inc.
Target Recruit Count
28
Registration Number
NCT01366365
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States

Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX

Phase 1
Completed
Conditions
Interventions
First Posted Date
2011-06-06
Last Posted Date
2019-11-27
Lead Sponsor
Bausch Health Americas, Inc.
Target Recruit Count
18
Registration Number
NCT01366378
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States

Tolerance and Pharmacokinetics Study of MNTX Tablets

First Posted Date
2011-06-06
Last Posted Date
2019-11-27
Lead Sponsor
Bausch Health Americas, Inc.
Target Recruit Count
37
Registration Number
NCT01366339
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Progenics Pharmaceuticals, Inc., Tarrytown, New York, United States

Effect of Methylnaltrexone (MNTX) on Electrocardiogram (ECG) Parameters and Cardiac Repolarization

First Posted Date
2011-06-01
Last Posted Date
2019-11-29
Lead Sponsor
Bausch Health Americas, Inc.
Target Recruit Count
546
Registration Number
NCT01363323
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Progenics Pharmaceuticals, Tarrytown, New York, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath